Prologis Pharmaceutical: Announcement on foreign investment of subsidiary companies
Prologis Pharmaceuticals: Progress Announcement on the Repurchase of the Company\'s Shares
Proglo Pharmaceutical: Announcement on the progress of guarantees for subsidiary companies
Apeloa Pharmaceutical: Investor relations activity record form for August 16, 2024.
Apeloa Pharmaceutical: Summary of Half-Year Report in 2024.
Apeloa Pharmaceutical: Half-year report for the year 2024.
Apeloa Pharmaceutical: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.
Apeloa Pharmaceutical: Financial Report for the first half of 2024.
Apeloa Pharmaceutical: Announcement regarding the progress of repurchasing company shares.
Apeloa Pharmaceutical: Announcement on Progress Made Regarding Guarantees for Subsidiary Companies.
Apeloa Pharmaceutical: Announcement Regarding the Approval by the USA FDA for Products of our wholly-owned Subsidiary.
Apeloa Pharmaceutical: Announcement regarding the progress of repurchasing company shares.
Apeloa Pharmaceutical: Announcement on Progress Made Regarding Guarantees for Subsidiary Companies.
Apeloa Pharmaceutical: Announcement on the completion of share repurchase cancellation and changes in shareholding
Apeloa Pharmaceutical: Announcement regarding the progress of repurchasing company shares.
Apeloa Pharmaceutical: Announcement on the progress of guarantees for subsidiary companies
Apeloa Pharmaceutical: 2023 dividend payment implementation announcement
Apeloa Pharmaceutical: Announcement on the progress of the repurchase of company shares
Prologis Pharmaceuticals: Investor Relations Activity Record Form for April 18, 2024
Prologis Pharmaceuticals: Report for the first quarter of 2024
No Data
No Data